Lilly to acquire Boston-based gene therapy firm for $487M
The Indianapolis-based drugmaker said it has reached a definitive agreement to acquire Akouos Inc., a seven-year-old biotech firm, which is running early clinical trials for its lead therapy for hearing loss.